You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,010,530


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,010,530 protect, and when does it expire?

Patent 10,010,530 protects NUBEQA and is included in one NDA.

This patent has fourteen patent family members in twelve countries.

Summary for Patent: 10,010,530
Title:Carboxamide derivative and its diastereomers in stable crystalline form
Abstract: The present disclosure relates to solid crystalline forms of N--((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-5-(1-- hydroxyethyl)-1H-pyrazole-3-carboxamide (I) and the diastereomers thereof, and to methods for preparing such crystalline forms. Compound (I) and the diastereomers thereof are potent androgen receptor (AR) modulators useful as a medicament. ##STR00001##
Inventor(s): Tormakangas; Olli (Turku, FI), Heikkinen; Terhi (Lieto, FI)
Assignee: Orlon Corporation (Espoo, FI)
Application Number:15/547,193
Patent Claim Types:
see list of patent claims
Compound; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,010,530: A Comprehensive Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 10,010,530, it is crucial to delve into the specifics of its scope and claims. This patent, like any other, is a complex document that requires a thorough understanding of its various components. Here, we will break down the key elements of this patent, including its background, summary, claims, and the broader patent landscape.

Background and Summary of the Invention

The Background and Summary of the Invention sections in a patent provide a detailed description of the invention, its context, and its significance. For U.S. Patent 10,010,530, these sections would typically outline the problem the invention addresses, the state of the art at the time of filing, and how the invention improves upon existing solutions[4].

Identifying the Problem

The background section often highlights the specific technical problem or need that the invention aims to solve. This could involve discussing existing technologies, their limitations, and why a new solution is necessary.

Describing the Invention

The summary section provides a concise overview of the invention itself, including its main components, how it works, and its key features. This section is crucial for understanding the core innovation and its practical applications.

The Claims: Defining the Scope of the Invention

The claims section is the most critical part of a patent, as it defines the legal boundaries of what is protected.

Structure of Claims

Claims are set forth as separately numbered paragraphs in a single-sentence format. The first claim is always numbered "1," and subsequent claims follow in an ascending numerical sequence. Most patents contain between 10-20 claims, although some may have only one or hundreds[5].

Independent and Dependent Claims

  • Independent Claims: These stand alone and do not refer to any other claims. They define the broadest scope of the invention.
  • Dependent Claims: These refer back to and further limit the scope of an independent claim. They often add specific details or features to the independent claim.

Claim Language and Scope

The language used in the claims is precise and technical. It must be clear and concise to avoid ambiguity. The scope of the claims is determined by the words used, and any interpretation must be based on the specification and the drawings provided in the patent[5].

Analyzing the Claims of U.S. Patent 10,010,530

To analyze the claims of this patent, one must carefully read each claim and understand how they interrelate.

Identifying Key Elements

Each claim will identify specific elements or features of the invention. For example, if the patent is for an AI-related invention, the claims might detail specific algorithms, data structures, or system architectures.

Evaluating Claim Scope

The scope of the claims can be evaluated by looking at the independent claim length and count, as well as the dependency relationships between claims. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Patent Eligibility Under 35 U.S.C. ยง 101

For AI inventions like U.S. Patent 10,010,530, overcoming section 101 rejections is a significant challenge.

The Two-Pronged Framework

The USPTO uses a two-pronged framework to evaluate patent eligibility:

  • Prong One: Determine if the claim recites an abstract idea.
  • Prong Two: If it does, evaluate whether the claim elements beyond the abstract idea integrate it into a practical application, showing an improvement in computer functionality or another technology or technical field[1].

Crafting Effective Arguments

To overcome section 101 rejections, it is crucial to build a compelling narrative around the main novelty of the claimed invention. This involves demonstrating that the claims reflect a specific, concrete technological advancement or solution to a technical problem. The argument must be supported by the specification and should guide the examiner through a clear and logical progression from the technical problem to the claimed innovation[1].

The Role of the Specification

The specification is essential in supporting the claims and demonstrating the practical utility and real-world impact of the invention.

Technical Explanations

The specification must provide technical explanations of the asserted improvements and evaluate whether the claim accurately reflects those improvements. This ensures that the examiner can see how the claimed invention improves the functioning of a computer or another technology or technical field[1].

Patent Landscape and Related Patents

Understanding the broader patent landscape is vital for assessing the novelty and non-obviousness of the invention.

U.S. Classification and International Classification

The U.S. Classification system and International Classification help in identifying similar patents and organizing them by how they work. This is crucial for conducting comprehensive preliminary patent searches and identifying prior art[4].

References Cited

The references cited section lists patents and other publications that are similar or related to the invention. These can be a rich source for traditional literature and articles, and they help in understanding the state of the art at the time of filing[4].

Challenges in Overcoming Section 101 Rejections

Overcoming section 101 rejections can be challenging, especially when dealing with AI inventions.

Examiner Dynamics

Examiners have limited time and attention, and lengthy arguments under Prong One can consume a significant portion of their attention, potentially leaving less focus for Prong Two. This can diminish the impact of the more persuasive arguments related to technological improvement and practical application[1].

Supervisory Influence

In some cases, the primary examiner may not be the main driving force behind the issuance of a section 101 rejection. Instead, they may be acting under the direction of their supervisory patent examiner (SPE) or a section 101 specialist, which poses a greater challenge for applicants[1].

Key Takeaways

  • Claims Define Scope: The claims section is critical in defining the legal boundaries of what is protected by the patent.
  • Patent Eligibility: Overcoming section 101 rejections requires demonstrating that the claims integrate an abstract idea into a practical application, showing an improvement in computer functionality or another technology.
  • Specification Support: The specification must provide technical explanations to support the claims and demonstrate practical utility.
  • Patent Landscape: Understanding the broader patent landscape is essential for assessing novelty and non-obviousness.
  • Examiner Dynamics: Crafting persuasive arguments that are concise and focused on Prong Two can be crucial in overcoming section 101 rejections.

FAQs

Q: What is the significance of the two-pronged framework in evaluating patent eligibility?

A: The two-pronged framework helps determine if a claim recites an abstract idea and, if so, whether it integrates the abstract idea into a practical application, showing an improvement in computer functionality or another technology.

Q: How do independent and dependent claims differ?

A: Independent claims stand alone and define the broadest scope of the invention, while dependent claims refer back to and further limit the scope of an independent claim.

Q: What role does the specification play in supporting the claims?

A: The specification provides technical explanations to support the claims, demonstrating the practical utility and real-world impact of the invention.

Q: Why is understanding the patent landscape important?

A: Understanding the patent landscape helps in identifying similar patents, assessing novelty and non-obviousness, and conducting comprehensive preliminary patent searches.

Q: What challenges do applicants face when dealing with section 101 rejections?

A: Applicants face challenges such as limited examiner attention, potential bias from lengthy arguments, and the influence of supervisory patent examiners or section 101 specialists.

Sources

  1. The Importance of Prong Two of Step 2A for AI Inventions - Baker Botts
  2. Patent Claims Research Dataset - USPTO
  3. Patent Claims and Patent Scope - SSRN
  4. Patents Online: Basics for Researchers: Reading a U.S. Patent - Oklahoma State University Library
  5. Reading and Understanding Patent Claims - The Minerals, Metals & Materials Society (TMS)

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,010,530

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bayer Healthcare NUBEQA darolutamide TABLET;ORAL 212099-001 Jul 30, 2019 RX Yes Yes 10,010,530 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,010,530

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Finland20150033Jan 30, 2015
PCT Information
PCT FiledJanuary 28, 2016PCT Application Number:PCT/FI2016/050054
PCT Publication Date:August 04, 2016PCT Publication Number: WO2016/120530

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.